Danaher Partners with the University of Pennsylvania's Center for Cellular Immunotherapies to Address Manufacturing Challenges Impacting the Uptake of Cell Therapies
Danaher Partners with the University of Pennsylvania’s Center for Cellular Immunotherapies to Address Manufacturing Challenges Impacting the Uptake of Cell Therapies WASHINGTON, March 7, 2023 /PRNewswire/ — Danaher Corporation (NYSE: DHR), a global science and technology innovator, today announced a strategic partnership with the University of Pennsylvania (Penn) focusing on cell therapy innovation. The multi-year... Read more
Bruker Launches de novo Sequencing for Immunopeptidomics, Library-Free dia-PASEF, Mass Dynamics Knowledge Visualization
PaSER™ Novor faster, real-time de novo sequencing for immunopeptidomics Library-free dia-PASEF® analysis with PaSER 2023b proteomics software Partnership with Mass Dynamics for 4D-Proteomics™ knowledge visualization CHICAGO–(BUSINESS WIRE)– At the 19th US HUPO, Bruker Corporation (Nasdaq: BRKR) announced important bioinformatics launches for 4D-Proteomics on the timsTOF platform: A novel de novo sequencing algorithm was developed in... Read more